img

Global CD40 Ligand Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global CD40 Ligand Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

CD40 Ligand report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global CD40 Ligand market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hepatitis B and Bladder Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for CD40 Ligand industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, CD40 Ligand key manufacturers include Biogen, Inc., Bristol-Myers Squibb Company, eTheRNA Immunotherapies NV, ImmuNext, Inc., Juno Therapeutics Inc., MedImmune, LLC, Targovax AS and XL-protein GmbH, etc. Biogen, Inc., Bristol-Myers Squibb Company, eTheRNA Immunotherapies NV are top 3 players and held % sales share in total in 2022.
CD40 Ligand can be divided into ISF-35, LOAd-700, MEDI-4920 and MegaCD40L, etc. ISF-35 is the mainstream product in the market, accounting for % sales share globally in 2022.
CD40 Ligand is widely used in various fields, such as Hepatitis B, Bladder Cancer, Liver Cancer and Ovarian Cancer, etc. Hepatitis B provides greatest supports to the CD40 Ligand industry development. In 2022, global % sales of CD40 Ligand went into Hepatitis B filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CD40 Ligand market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Biogen, Inc.
Bristol-Myers Squibb Company
eTheRNA Immunotherapies NV
ImmuNext, Inc.
Juno Therapeutics Inc.
MedImmune, LLC
Targovax AS
XL-protein GmbH
Segment by Type
ISF-35
LOAd-700
MEDI-4920
MegaCD40L
Others

Segment by Application


Hepatitis B
Bladder Cancer
Liver Cancer
Ovarian Cancer
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CD40 Ligand market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of CD40 Ligand, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the CD40 Ligand industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of CD40 Ligand in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, CD40 Ligand introduction, etc. CD40 Ligand Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of CD40 Ligand market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 CD40 Ligand Market Overview
1.1 CD40 Ligand Product Overview
1.2 CD40 Ligand Market Segment by Type
1.2.1 ISF-35
1.2.2 LOAd-700
1.2.3 MEDI-4920
1.2.4 MegaCD40L
1.2.5 Others
1.3 Global CD40 Ligand Market Size by Type
1.3.1 Global CD40 Ligand Market Size Overview by Type (2018-2034)
1.3.2 Global CD40 Ligand Historic Market Size Review by Type (2018-2024)
1.3.3 Global CD40 Ligand Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America CD40 Ligand Sales Breakdown by Type (2018-2024)
1.4.2 Europe CD40 Ligand Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific CD40 Ligand Sales Breakdown by Type (2018-2024)
1.4.4 Latin America CD40 Ligand Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa CD40 Ligand Sales Breakdown by Type (2018-2024)
2 Global CD40 Ligand Market Competition by Company
2.1 Global Top Players by CD40 Ligand Sales (2018-2024)
2.2 Global Top Players by CD40 Ligand Revenue (2018-2024)
2.3 Global Top Players by CD40 Ligand Price (2018-2024)
2.4 Global Top Manufacturers CD40 Ligand Manufacturing Base Distribution, Sales Area, Product Type
2.5 CD40 Ligand Market Competitive Situation and Trends
2.5.1 CD40 Ligand Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by CD40 Ligand Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CD40 Ligand as of 2022)
2.7 Date of Key Manufacturers Enter into CD40 Ligand Market
2.8 Key Manufacturers CD40 Ligand Product Offered
2.9 Mergers & Acquisitions, Expansion
3 CD40 Ligand Status and Outlook by Region
3.1 Global CD40 Ligand Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global CD40 Ligand Historic Market Size by Region
3.2.1 Global CD40 Ligand Sales in Volume by Region (2018-2024)
3.2.2 Global CD40 Ligand Sales in Value by Region (2018-2024)
3.2.3 Global CD40 Ligand Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global CD40 Ligand Forecasted Market Size by Region
3.3.1 Global CD40 Ligand Sales in Volume by Region (2024-2034)
3.3.2 Global CD40 Ligand Sales in Value by Region (2024-2034)
3.3.3 Global CD40 Ligand Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global CD40 Ligand by Application
4.1 CD40 Ligand Market Segment by Application
4.1.1 Hepatitis B
4.1.2 Bladder Cancer
4.1.3 Liver Cancer
4.1.4 Ovarian Cancer
4.1.5 Others
4.2 Global CD40 Ligand Market Size by Application
4.2.1 Global CD40 Ligand Market Size Overview by Application (2018-2034)
4.2.2 Global CD40 Ligand Historic Market Size Review by Application (2018-2024)
4.2.3 Global CD40 Ligand Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America CD40 Ligand Sales Breakdown by Application (2018-2024)
4.3.2 Europe CD40 Ligand Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific CD40 Ligand Sales Breakdown by Application (2018-2024)
4.3.4 Latin America CD40 Ligand Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa CD40 Ligand Sales Breakdown by Application (2018-2024)
5 North America CD40 Ligand by Country
5.1 North America CD40 Ligand Historic Market Size by Country
5.1.1 North America CD40 Ligand Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America CD40 Ligand Sales in Volume by Country (2018-2024)
5.1.3 North America CD40 Ligand Sales in Value by Country (2018-2024)
5.2 North America CD40 Ligand Forecasted Market Size by Country
5.2.1 North America CD40 Ligand Sales in Volume by Country (2024-2034)
5.2.2 North America CD40 Ligand Sales in Value by Country (2024-2034)
6 Europe CD40 Ligand by Country
6.1 Europe CD40 Ligand Historic Market Size by Country
6.1.1 Europe CD40 Ligand Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe CD40 Ligand Sales in Volume by Country (2018-2024)
6.1.3 Europe CD40 Ligand Sales in Value by Country (2018-2024)
6.2 Europe CD40 Ligand Forecasted Market Size by Country
6.2.1 Europe CD40 Ligand Sales in Volume by Country (2024-2034)
6.2.2 Europe CD40 Ligand Sales in Value by Country (2024-2034)
7 Asia-Pacific CD40 Ligand by Region
7.1 Asia-Pacific CD40 Ligand Historic Market Size by Region
7.1.1 Asia-Pacific CD40 Ligand Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific CD40 Ligand Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific CD40 Ligand Sales in Value by Region (2018-2024)
7.2 Asia-Pacific CD40 Ligand Forecasted Market Size by Region
7.2.1 Asia-Pacific CD40 Ligand Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific CD40 Ligand Sales in Value by Region (2024-2034)
8 Latin America CD40 Ligand by Country
8.1 Latin America CD40 Ligand Historic Market Size by Country
8.1.1 Latin America CD40 Ligand Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America CD40 Ligand Sales in Volume by Country (2018-2024)
8.1.3 Latin America CD40 Ligand Sales in Value by Country (2018-2024)
8.2 Latin America CD40 Ligand Forecasted Market Size by Country
8.2.1 Latin America CD40 Ligand Sales in Volume by Country (2024-2034)
8.2.2 Latin America CD40 Ligand Sales in Value by Country (2024-2034)
9 Middle East and Africa CD40 Ligand by Country
9.1 Middle East and Africa CD40 Ligand Historic Market Size by Country
9.1.1 Middle East and Africa CD40 Ligand Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa CD40 Ligand Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa CD40 Ligand Sales in Value by Country (2018-2024)
9.2 Middle East and Africa CD40 Ligand Forecasted Market Size by Country
9.2.1 Middle East and Africa CD40 Ligand Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa CD40 Ligand Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Biogen, Inc.
10.1.1 Biogen, Inc. Company Information
10.1.2 Biogen, Inc. Introduction and Business Overview
10.1.3 Biogen, Inc. CD40 Ligand Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Biogen, Inc. CD40 Ligand Products Offered
10.1.5 Biogen, Inc. Recent Development
10.2 Bristol-Myers Squibb Company
10.2.1 Bristol-Myers Squibb Company Company Information
10.2.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.2.3 Bristol-Myers Squibb Company CD40 Ligand Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bristol-Myers Squibb Company CD40 Ligand Products Offered
10.2.5 Bristol-Myers Squibb Company Recent Development
10.3 eTheRNA Immunotherapies NV
10.3.1 eTheRNA Immunotherapies NV Company Information
10.3.2 eTheRNA Immunotherapies NV Introduction and Business Overview
10.3.3 eTheRNA Immunotherapies NV CD40 Ligand Sales, Revenue and Gross Margin (2018-2024)
10.3.4 eTheRNA Immunotherapies NV CD40 Ligand Products Offered
10.3.5 eTheRNA Immunotherapies NV Recent Development
10.4 ImmuNext, Inc.
10.4.1 ImmuNext, Inc. Company Information
10.4.2 ImmuNext, Inc. Introduction and Business Overview
10.4.3 ImmuNext, Inc. CD40 Ligand Sales, Revenue and Gross Margin (2018-2024)
10.4.4 ImmuNext, Inc. CD40 Ligand Products Offered
10.4.5 ImmuNext, Inc. Recent Development
10.5 Juno Therapeutics Inc.
10.5.1 Juno Therapeutics Inc. Company Information
10.5.2 Juno Therapeutics Inc. Introduction and Business Overview
10.5.3 Juno Therapeutics Inc. CD40 Ligand Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Juno Therapeutics Inc. CD40 Ligand Products Offered
10.5.5 Juno Therapeutics Inc. Recent Development
10.6 MedImmune, LLC
10.6.1 MedImmune, LLC Company Information
10.6.2 MedImmune, LLC Introduction and Business Overview
10.6.3 MedImmune, LLC CD40 Ligand Sales, Revenue and Gross Margin (2018-2024)
10.6.4 MedImmune, LLC CD40 Ligand Products Offered
10.6.5 MedImmune, LLC Recent Development
10.7 Targovax AS
10.7.1 Targovax AS Company Information
10.7.2 Targovax AS Introduction and Business Overview
10.7.3 Targovax AS CD40 Ligand Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Targovax AS CD40 Ligand Products Offered
10.7.5 Targovax AS Recent Development
10.8 XL-protein GmbH
10.8.1 XL-protein GmbH Company Information
10.8.2 XL-protein GmbH Introduction and Business Overview
10.8.3 XL-protein GmbH CD40 Ligand Sales, Revenue and Gross Margin (2018-2024)
10.8.4 XL-protein GmbH CD40 Ligand Products Offered
10.8.5 XL-protein GmbH Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 CD40 Ligand Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 CD40 Ligand Industrial Chain Analysis
11.4 CD40 Ligand Market Dynamics
11.4.1 CD40 Ligand Industry Trends
11.4.2 CD40 Ligand Market Drivers
11.4.3 CD40 Ligand Market Challenges
11.4.4 CD40 Ligand Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 CD40 Ligand Distributors
12.3 CD40 Ligand Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of ISF-35
Table 2. Major Company of LOAd-700
Table 3. Major Company of MEDI-4920
Table 4. Major Company of MegaCD40L
Table 5. Major Company of Others
Table 6. Global CD40 Ligand Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global CD40 Ligand Sales by Type (2018-2024) & (K Pcs)
Table 8. Global CD40 Ligand Sales Market Share in Volume by Type (2018-2024)
Table 9. Global CD40 Ligand Sales by Type (2018-2024) & (US& Million)
Table 10. Global CD40 Ligand Market Share in Value by Type (2018-2024)
Table 11. Global CD40 Ligand Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global CD40 Ligand Sales by Type (2024-2034) & (K Pcs)
Table 13. Global CD40 Ligand Sales Market Share in Volume by Type (2024-2034)
Table 14. Global CD40 Ligand Sales by Type (2024-2034) & (US$ Million)
Table 15. Global CD40 Ligand Sales Market Share in Value by Type (2024-2034)
Table 16. Global CD40 Ligand Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America CD40 Ligand Sales by Type (2018-2024) & (K Pcs)
Table 18. North America CD40 Ligand Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe CD40 Ligand Sales (K Pcs) by Type (2018-2024)
Table 20. Europe CD40 Ligand Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific CD40 Ligand Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific CD40 Ligand Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America CD40 Ligand Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America CD40 Ligand Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa CD40 Ligand Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa CD40 Ligand Sales by Type (2018-2024) & (US$ Million)
Table 27. Global CD40 Ligand Sales by Company (2018-2024) & (K Pcs)
Table 28. Global CD40 Ligand Sales Share by Company (2018-2024)
Table 29. Global CD40 Ligand Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global CD40 Ligand Revenue Share by Company (2018-2024)
Table 31. Global Market CD40 Ligand Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global CD40 Ligand Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global CD40 Ligand Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CD40 Ligand as of 2022)
Table 35. Date of Key Manufacturers Enter into CD40 Ligand Market
Table 36. Key Manufacturers CD40 Ligand Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global CD40 Ligand Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global CD40 Ligand Sales by Region (2018-2024) & (K Pcs)
Table 40. Global CD40 Ligand Sales Market Share in Volume by Region (2018-2024)
Table 41. Global CD40 Ligand Sales by Region (2018-2024) & (US$ Million)
Table 42. Global CD40 Ligand Sales Market Share in Value by Region (2018-2024)
Table 43. Global CD40 Ligand Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global CD40 Ligand Sales by Region (2024-2034) & (K Pcs)
Table 45. Global CD40 Ligand Sales Market Share in Volume by Region (2024-2034)
Table 46. Global CD40 Ligand Sales by Region (2024-2034) & (US$ Million)
Table 47. Global CD40 Ligand Sales Market Share in Value by Region (2024-2034)
Table 48. Global CD40 Ligand Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global CD40 Ligand Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global CD40 Ligand Sales by Application (2018-2024) & (K Pcs)
Table 51. Global CD40 Ligand Sales Market Share in Volume by Application (2018-2024)
Table 52. Global CD40 Ligand Sales by Application (2018-2024) & (US$ Million)
Table 53. Global CD40 Ligand Sales Market Share in Value by Application (2018-2024)
Table 54. Global CD40 Ligand Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global CD40 Ligand Sales by Application (2024-2034) & (K Pcs)
Table 56. Global CD40 Ligand Sales Market Share in Volume by Application (2024-2034)
Table 57. Global CD40 Ligand Sales by Application (2024-2034) & (US$ Million)
Table 58. Global CD40 Ligand Sales Market Share in Value by Application (2024-2034)
Table 59. Global CD40 Ligand Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America CD40 Ligand Sales by Application (2018-2024) (K Pcs)
Table 61. North America CD40 Ligand Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe CD40 Ligand Sales by Application (2018-2024) (K Pcs)
Table 63. Europe CD40 Ligand Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific CD40 Ligand Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific CD40 Ligand Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America CD40 Ligand Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America CD40 Ligand Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa CD40 Ligand Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa CD40 Ligand Sales by Application (2018-2024) & (US$ Million)
Table 70. North America CD40 Ligand Sales by Country (2018-2024) & (K Pcs)
Table 71. North America CD40 Ligand Sales Market Share in Volume by Country (2018-2024)
Table 72. North America CD40 Ligand Sales by Country (2018-2024) & (US$ Million)
Table 73. North America CD40 Ligand Sales Market Share in Value by Country (2018-2024)
Table 74. North America CD40 Ligand Sales by Country (2024-2034) & (K Pcs)
Table 75. North America CD40 Ligand Sales Market Share in Volume by Country (2024-2034)
Table 76. North America CD40 Ligand Sales by Country (2024-2034) & (US$ Million)
Table 77. North America CD40 Ligand Sales Market Share in Value by Country (2024-2034)
Table 78. Europe CD40 Ligand Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe CD40 Ligand Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe CD40 Ligand Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe CD40 Ligand Sales Market Share in Value by Country (2018-2024)
Table 82. Europe CD40 Ligand Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe CD40 Ligand Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe CD40 Ligand Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe CD40 Ligand Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific CD40 Ligand Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific CD40 Ligand Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific CD40 Ligand Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific CD40 Ligand Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific CD40 Ligand Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific CD40 Ligand Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific CD40 Ligand Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific CD40 Ligand Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America CD40 Ligand Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America CD40 Ligand Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America CD40 Ligand Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America CD40 Ligand Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America CD40 Ligand Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America CD40 Ligand Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America CD40 Ligand Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America CD40 Ligand Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa CD40 Ligand Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa CD40 Ligand Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa CD40 Ligand Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa CD40 Ligand Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa CD40 Ligand Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa CD40 Ligand Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa CD40 Ligand Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa CD40 Ligand Sales Market Share in Value by Country (2024-2034)
Table 110. Biogen, Inc. Company Information
Table 111. Biogen, Inc. Introduction and Business Overview
Table 112. Biogen, Inc. CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Biogen, Inc. CD40 Ligand Product
Table 114. Biogen, Inc. Recent Development
Table 115. Bristol-Myers Squibb Company Company Information
Table 116. Bristol-Myers Squibb Company Introduction and Business Overview
Table 117. Bristol-Myers Squibb Company CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Bristol-Myers Squibb Company CD40 Ligand Product
Table 119. Bristol-Myers Squibb Company Recent Development
Table 120. eTheRNA Immunotherapies NV Company Information
Table 121. eTheRNA Immunotherapies NV Introduction and Business Overview
Table 122. eTheRNA Immunotherapies NV CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. eTheRNA Immunotherapies NV CD40 Ligand Product
Table 124. eTheRNA Immunotherapies NV Recent Development
Table 125. ImmuNext, Inc. Company Information
Table 126. ImmuNext, Inc. Introduction and Business Overview
Table 127. ImmuNext, Inc. CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. ImmuNext, Inc. CD40 Ligand Product
Table 129. ImmuNext, Inc. Recent Development
Table 130. Juno Therapeutics Inc. Company Information
Table 131. Juno Therapeutics Inc. Introduction and Business Overview
Table 132. Juno Therapeutics Inc. CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Juno Therapeutics Inc. CD40 Ligand Product
Table 134. Juno Therapeutics Inc. Recent Development
Table 135. MedImmune, LLC Company Information
Table 136. MedImmune, LLC Introduction and Business Overview
Table 137. MedImmune, LLC CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. MedImmune, LLC CD40 Ligand Product
Table 139. MedImmune, LLC Recent Development
Table 140. Targovax AS Company Information
Table 141. Targovax AS Introduction and Business Overview
Table 142. Targovax AS CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Targovax AS CD40 Ligand Product
Table 144. Targovax AS Recent Development
Table 145. XL-protein GmbH Company Information
Table 146. XL-protein GmbH Introduction and Business Overview
Table 147. XL-protein GmbH CD40 Ligand Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. XL-protein GmbH CD40 Ligand Product
Table 149. XL-protein GmbH Recent Development
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. CD40 Ligand Market Trends
Table 153. CD40 Ligand Market Drivers
Table 154. CD40 Ligand Market Challenges
Table 155. CD40 Ligand Market Restraints
Table 156. CD40 Ligand Distributors List
Table 157. CD40 Ligand Downstream Customers
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. CD40 Ligand Product Picture
Figure 2. Global CD40 Ligand Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global CD40 Ligand Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global CD40 Ligand Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of ISF-35
Figure 6. Global ISF-35 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of LOAd-700
Figure 8. Global LOAd-700 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of MEDI-4920
Figure 10. Global MEDI-4920 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of MegaCD40L
Figure 12. Global MegaCD40L Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global CD40 Ligand Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global CD40 Ligand Sales Market Share by Type in 2022 & 2034
Figure 17. North America CD40 Ligand Sales Market Share in Volume by Type in 2022
Figure 18. North America CD40 Ligand Sales Market Share in Value by Type in 2022
Figure 19. Europe CD40 Ligand Sales Market Share in Volume by Type in 2022
Figure 20. Europe CD40 Ligand Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific CD40 Ligand Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific CD40 Ligand Sales Market Share in Value by Type in 2022
Figure 23. Latin America CD40 Ligand Sales Market Share in Volume by Type in 2022
Figure 24. Latin America CD40 Ligand Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa CD40 Ligand Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa CD40 Ligand Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by CD40 Ligand Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by CD40 Ligand Revenue in 2022
Figure 29. CD40 Ligand Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Hepatitis B
Figure 31. Global Hepatitis B Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Bladder Cancer
Figure 33. Global Bladder Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Liver Cancer
Figure 35. Global Liver Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Ovarian Cancer
Figure 37. Global Ovarian Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Global CD40 Ligand Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global CD40 Ligand Sales Market Share by Application in 2022 & 2034
Figure 42. North America CD40 Ligand Sales Market Share in Volume by Application in 2022
Figure 43. North America CD40 Ligand Sales Market Share in Value by Application in 2022
Figure 44. Europe CD40 Ligand Sales Market Share in Volume by Application in 2022
Figure 45. Europe CD40 Ligand Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific CD40 Ligand Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific CD40 Ligand Sales Market Share in Value by Application in 2022
Figure 48. Latin America CD40 Ligand Sales Market Share in Volume by Application in 2022
Figure 49. Latin America CD40 Ligand Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa CD40 Ligand Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. CD40 Ligand Manufacturing Cost Structure
Figure 53. CD40 Ligand Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries